Log in
Enquire now
‌

US Patent 11891452 Anti-kit antibodies and uses thereof

Patent 11891452 was granted and assigned to Celldex Therapeutics on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Celldex Therapeutics
Celldex Therapeutics
0
Current Assignee
Celldex Therapeutics
Celldex Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118914520
Patent Inventor Names
Francis Joseph Carr0
Elizabeth M Mandel-Bausch0
Yaron Hadari0
Timothy David Jones0
Laura Clare Alexandra Perry0
Date of Patent
February 6, 2024
0
Patent Application Number
169849460
Date Filed
August 4, 2020
0
Patent Citations
‌
US Patent 7449309 Methods for desensitizing a subject to an agent
0
‌
US Patent 7906302 Methods of preventing or treating contact dermatitis
0
‌
US Patent 7915391 Humanized c-Kit antibody
0
‌
US Patent 7959942 Bioabsorbable medical device with coating
0
‌
US Patent 8088060 Progenitor endothelial cell capturing with a drug eluting implantable medical device
0
‌
US Patent 8133485 Bi-specific complexes for targeting cells involved in allergic-type reactions, compositions and uses thereof
0
‌
US Patent 8133733 Nonviral vectors for delivering polynucleotides to target tissues
0
‌
US Patent 8278067 Method for inhibiting hyperpigmentation
0
...
Patent Primary Examiner
‌
Nora M Rooney
0
Patent abstract

Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-associated disorder or disease and methods of diagnosing a KIT-associated disorder or disease using the antibodies described herein.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11891452 Anti-kit antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.